HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Osteogenic sarcoma and myasthenia gravis in a dog.

Abstract
A 7-year-old Saint Bernard developed muscular weakness 1 year after right forelimb amputation and adjuvant cisplatin chemotherapy for osteogenic sarcoma. Clinical and laboratory findings supported a diagnosis of myasthenia gravis, and the dog had clinical improvement in response to prednisone treatment. Two additional dogs with myasthenia gravis and osteogenic sarcoma were identified by review of the medical records of the University of California Veterinary Medical Teaching Hospital. Findings indicated that myasthenia gravis or other neuromuscular transmission disorders may be associated with muscular weakness in dogs with osteogenic sarcoma.
AuthorsA S Moore, B R Madewell, G H Cardinet 3rd, G D Shelton
JournalJournal of the American Veterinary Medical Association (J Am Vet Med Assoc) Vol. 197 Issue 2 Pg. 226-7 (Jul 15 1990) ISSN: 0003-1488 [Print] UNITED STATES
PMID2384323 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cisplatin
Topics
  • Animals
  • Bone Neoplasms (complications, drug therapy, veterinary)
  • Cisplatin (adverse effects, therapeutic use)
  • Dog Diseases
  • Dogs
  • Forelimb
  • Male
  • Myasthenia Gravis (chemically induced, complications, veterinary)
  • Osteosarcoma (complications, drug therapy, veterinary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: